SureNano Science Ltd.
Sign in to search companies, open filing PDFs, fetch uncached SEDAR+ documents, and use the
full company research view.
News 2026-04-24
SureNano Science Initiates FDA Stage GLP Toxicology and Pharmacology Studies for GLP GEP-44 and Enters Discussions to Acquire Ibogaine Formulation IP Portfolio
News release - English.pdf
Transactions 2026-02-24 M&A
SureNano Science Ltd. Announces Closing of GlucaPharm Acquisition
Material change report - English.pdf
Transactions 2026-02-23 M&A
SureNano Science Ltd. Acquires GlucaPharm Inc., Advancing Second-Generation FDA Pathway GLP-1 Drug Development
News release - English.pdf
Results 2026-02-10 Financials
Interim MD&A - English.pdf
Results 2026-02-10 Financials
Interim financial statements/report – English.pdf
News 2025-12-19
Report of exempt distribution (45-106F1).pdf
Transactions 2025-12-18 Financing
SureNano Announces Closing of $1,250,000 Private Placement
Material change report - English.pdf
Transactions 2025-12-10 Financing
SureNano Announces Closing of $1,250,000 Private Placement
News release - English.pdf
Transactions 2025-11-19 M&A
SureNano Announces Non-Binding Letter of Intent to Negotiate Proposed Transaction of GlucaPharm Inc. for GLP-1 Drug Development
News release - English.pdf
Results 2025-11-17 Financials
Interim MD&A - English.pdf
Results 2025-11-17 Financials
Interim financial statements/report – English.pdf
News 2025-11-06
News release - English.pdf
News 2025-09-26
Report of exempt distribution (45-106F1).pdf
News 2025-09-19
News release - English.pdf
News 2025-08-22
News release - English.pdf
Results 2025-08-01 Financials
Interim MD&A - English.pdf
Results 2025-08-01 Financials
Interim financial statements/report – English.pdf
News 2025-07-17
Other.pdf
Results 2025-06-05 Financials
Audited annual financial statements – English.pdf
Results 2025-06-05 Financials
Annual MD&A - English.pdf